Sonoma Pharmaceuticals to Exhibit at MEDICA 2025 in Düsseldorf

Core Viewpoint - Sonoma Pharmaceuticals, Inc. is set to showcase its patented Microcyn® technology-based products at MEDICA 2025, highlighting its leadership in the healthcare sector [1] Company Summary - Sonoma Pharmaceuticals specializes in developing and producing stabilized hypochlorous acid (HOCl) products for various applications, including wound care, eye, oral and nasal care, dermatological conditions, podiatry, and animal health care [1] Industry Summary - MEDICA 2025 is one of the largest and most prestigious medical B2B trade fairs globally, expected to attract 80,000 visitors from 72 countries and over 5,000 exhibitors [1]